Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.005 per share
Symbol
ERNA on Nasdaq
Shares outstanding
31,098,948
Price per share
$1.20
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
522,698
Total reported value
$627,089
% of total 13F portfolios
0%
Share change
+5,770
Value change
+$10,571
Number of holders
14
Price from insider filings
$1.20
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cherington Charles 35% $12,949,602 10,791,335 Charles Cherington 10 Feb 2026
Freebird Partners LP 9.9% $1,013,992 786,040 Freebird Partners LP 19 Dec 2025
Konar Shameek 7.1% $720,505 558,531 Shameek Konar 30 Jun 2025
IAF, LLC 4.1% $584,191 315,779 IAF, LLC 28 Jul 2025

As of 31 Dec 2025, 14 institutional investors reported holding 522,698 shares of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA). This represents 1.7% of the company’s total 31,098,948 outstanding shares.

Institutional Holders of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 522,698 $627,089 +$10,571 $1.20 14
2025 Q3 516,928 $566,036 +$511,087 $1.10 14
2025 Q2 49,811 $91,652 +$91,634 $1.84 12